Celularity Announces 1-for-10 Reverse Stock Split
FLORHAM PARK, N.J., Feb. 23, 2024 (GLOBE NEWSWIRE) -- Celularity, Inc. (Nasdaq: CELU; CELUW) (“Celularity”), a biotechnology company developing...
Stay updated with breaking news from Robertj Hariri. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
FLORHAM PARK, N.J., Feb. 23, 2024 (GLOBE NEWSWIRE) -- Celularity, Inc. (Nasdaq: CELU; CELUW) (“Celularity”), a biotechnology company developing...
FLORHAM PARK, N.J., Feb. 23, 2024 -- Celularity, Inc. , a biotechnology company developing allogeneic cell therapies and advanced biomaterial products, today announced that its Board of Directors...
25.01.2024 - Celularity closed two financing transactions on January 16, 2024, totaling $21 million in gross proceeds, consisting of a $6 million private placement with its largest investor, Dragasac Limited, and a $15 million amended and restated senior secured ... Seite 1
FLORHAM PARK, N.J., Jan. 18, 2024 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) has posted a Letter to Shareholders from Robert J. Hariri, M.D.,...
FLORHAM PARK, N.J., Jan. 18, 2024 -- Celularity Inc. has posted a Letter to Shareholders from Robert J. Hariri, M.D., Ph.D., Chairman, CEO, and Founder, which is included below and can also be...